BioBridgeXAll companies

Amygdala Neurosciences Inc

Biotechnology company · San Francisco, California, United States

Amygdala Neurosciences Inc is a biotechnology company headquartered in San Francisco, California, United States. Its earliest recorded incorporation is in 2015. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $2.3 million in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $5.6 million sold in a notice filed in 2019.

Profile compiled from public records. Is this your company? Request a correction or update

Amygdala Neurosciences at a glance

Typebiotechnology company
HeadquartersSan Francisco, California, United States
Earliest incorporation on record2015
Employees (per SBIR records)2
SEC CIK1640814

What does Amygdala Neurosciences do?

US government research funding

2 SBIR/STTR small-business research awards from US health agencies, $2.3 million in total (2021 to 2023). NIH funding came from the National Institute on Alcohol Abuse and Alcoholism.

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $5.6 million sold (2019).

Frequently asked questions about Amygdala Neurosciences

Where is Amygdala Neurosciences headquartered?

Amygdala Neurosciences Inc is headquartered in San Francisco, California, United States.

What does Amygdala Neurosciences do?

Amygdala Neurosciences Inc is a biotechnology company.

When was Amygdala Neurosciences founded?

The earliest incorporation on record for Amygdala Neurosciences Inc is in 2015, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.